Hepatotoxicity of statins and other lipid-lowering agents-Reference-Cited by-同舟云学术

Hepatotoxicity of statins and other lipid-lowering agents

Published:2016-11-27 Issue:2 Volume:37 Page:173-178
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Björnsson Einar S.¹²

Affiliation:

1. Faculty of Medicine; The National University Hospital of Iceland; Reykjavik Iceland

2. Faculty of Medicine; University of Iceland; Reykjavik Iceland

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13308/fullpdf

Reference50 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Pedersen;Lancet,1994

2. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia;Bradford;Arch Intern Med,1999

3. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial;Schwartz;JAMA,2001

4. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group;Shepherd;N Engl J Med,1995

5. Evolution of the Food and Drug Administration approach to liver safety assessment for new drugs: current status and challenges;Senior;Drug Saf,2014

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Passiflora edulis extract ameliorates HFD-induced hepatic steatosis mediated through Nrf2 and IRS-1 activation, NFκB suppression, and hepatic lipid metabolism and bile acid modulation in obese rats;Journal of Functional Foods;2024-09

2. Attenuation of high-fat high-sucrose diet and CCl4-induced non-alcoholic steatohepatitis in rats by activating autophagy and SIGMAR1/GRP78/ITPR1 signaling using berberine-loaded albumin nanoparticles: in vivo prediction and in-silico molecular modeling;Journal of Pharmaceutical Investigation;2024-08-16

3. The Oxidative Stress Markers’ Protective Influence of Sea Buckthorn and Grape Extracts in Atorvastatin-Treated Hyperlipidemic Rats;Nutrients;2024-06-19

4. Rare Clinically Significant Idiosyncratic Drug Induced Liver Injury Caused by Low Dose Atorvastatin: Time for a New Approach to Surveillance and Risk Identification;International Journal of Gastroenterology;2024-06-06

5. Treatment of Hyperlipidemia With Alirocumab in a Liver Transplant Recipient With Poor Blood Lipid Control: Case Report;Transplantation Proceedings;2024-06